NCT07501832 clinical trial report covering Bofanglutide, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07499115 clinical trial report covering Chitosan, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07499674 clinical trial report covering VGT-309, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

CTR20254614 clinical trial report covering HR1405-01, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07500506 clinical trial report covering VLA15, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07499232 clinical trial report covering Risankizumab-RZAA, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07499544 clinical trial report covering Libevitug, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07502300 clinical trial report covering Tislelizumab, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

CTR20260987 clinical trial report covering Semaglutide (Shanxi Jiayuan), Phase 3, endpoints, sponsor, geography, readout timing and development white space

NCT07503730 clinical trial report covering Tretinoin, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07503600 clinical trial report covering Melatonin, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07503587 clinical trial report covering HSK-44459, Phase 3, endpoints, sponsor, geography, readout timing and development white space.